Protection of Stratospheric Ozone; Petitions for Exemption; Notice ENVIRONMENTAL PROTECTION AGENCY

SUMMARY: On September 13, 1994, the U.S. Environmental Protection

Agency (EPA) published a Federal Register notice (59 FR 47048) of

decision granting petitions for exemption for two specific applications

of products manufactured with class I substances. These waivers were

granted to the Upjohn Company (Upjohn) and E.I. DuPont de Nemours &

Company (Dupont). Within the notice of September 13, 1994, two

technical errors were made, one each in the Upjohn and Dupont

discussions. The purpose of today's action is to correct these

technical errors. The corrections are discussed in SUPPLEMENTARY

INFORMATION.

ADDRESSES: Copies of information relevant to these petitions are

available for inspection in public docket A-91-60 at the Air Docket

[LE-131 of EPA, Room M-1500, 401 M Street SW., Washington, DC 20460

between the hours of 8 a.m. to 5:30 p.m., Monday through Friday. A

reasonable fee may be charged for copying services.

FOR FURTHER INFORMATION CONTACT: Mavis Sanders, Stratospheric

Protection Division (6205-J), Office of Air and Radiation, U.S.

Environmental Protection Agency, 401 M Street SW., Washington, DC

20460, (202) 233-9737.

SUPPLEMENTARY INFORMATION:

Background

On February 11, 1993, the U.S. Environmental Protection Agency

(EPA) published the final labeling regulations implementing section 611

(58 FR 8136) of the Clean Air Act (CAA), as amended by the Clean Air

Act Amendments (CAAA) of 1990. The regulations include a section that

permits a manufacturer to petition EPA to temporarily exempt a product

manufactured with a class I substance from the labeling requirements.

This Action

When transcribing information from the Upjohn petition for

exemption, to the September 13, 1994 notice, EPA inadvertently listed

the wrong chemical as an actual alternative for the use of CFC-12 as a

stabilizer for Upjohn's sterilization process. The chemical

Spectinomycin Hydrochloride was stated as the replacement for the use

of CFC-12 in this process. The notice should have stated on page 47049

in the second column that Upjohn submitted a petition to the Food and

Drug Administration (FDA) to approve the modification of its use of a

CFC-12/Ethylene Oxide (ETO) mixture in the sterilization process to

100% Ethylene Oxide. Therefore, the notice of September 13, 1994, is

corrected to state that the alternative chemical submitted by Upjohn to

the Food and Drug Administration (FDA) for approval is ethylene oxide

(ETO).

There was a typographical error made in the E.I. Nemours Dupont

Company (Dupont) discussion of the notice. Dupont's petition requested

a waiver through December 31, 1996. EPA's intention was to grant a

waiver from labeling requirements, for the fine synthetic fiber

manufactured by Dupont, through December 31, 1996. The September 13,

1994, Federal Register notice stated on page 47051 in the first column

that the waiver should be granted through January 1, 1996. That notice

should have stated that the waiver be granted through December 31,

1996.

Therefore the notice of September 13, 1994 is corrected to grant

the waiver for Dupont's fine synthetic fiber through December 1996.

Dated: October 20, 1994.

Richard D. Wilson,

Acting Assistant Administrator.

[FR Doc. 94-26666 Filed 10-28-94; 8:45 am]

BILLING CODE 6560-50-P